Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Raltegravir Kaletra Pharmacokinetics (RAL-KAL)

This study has been completed.
Information provided by:
Allina Hospitals and Clinics Identifier:
First received: November 27, 2007
Last updated: June 16, 2008
Last verified: June 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)